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Neurotrypsin (NT) is a multi-domain serine-protease of the nervous system with only one 26 
known substrate: the large proteoglycan Agrin. NT has seen to be involved in the 27 
maintenance/turnover of neuromuscular junctions and in processes of synaptic plasticity in 28 
the central nervous system. Roles which have been tied to its enzymatic activity, localized in 29 
the C-terminal serine-protease (SP) domain. However the purpose of NT’s remaining 3-4 30 
scavenger receptor cysteine-rich (SRCR) domains is still unclear. We have determined the 31 
crystal structure of the third SRCR domain of murine NT (mmNT-SRCR3), immediately 32 
preceding the SP domain and performed a comparative structural analysis using homologous 33 
SRCR structures. Our data and the elevated degree of structural conservation with 34 
homologous domains highlight possible functional roles for NT SRCRs. Computational and 35 
experimental analyses suggest the identification of a putative binding region for Ca2+ ions, 36 
known to regulate NT enzymatic activity. Furthermore, sequence and structure comparisons 37 
allow to single out regions of interest that, in future studies, might be implicated in Agrin 38 
recognition/binding or in interactions with as of yet undiscovered NT partners.  39 
 40 
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Introduction  46 
Neurotrypsin (NT), also known as PRSS12 and motopsin, is a multi-domain extracellular 47 
serine-protease of the nervous system first described in the late 90's (1; 2). Spanning 761 48 
amino acids, the murine variant encompasses an N-terminal proline rich segment, a kringle 49 
domain (Kr), three scavenger receptor cysteine rich (SRCR) domains and a C-terminal 50 
serine-protease domain (SP) (1; 2). In comparison to the human homolog (875 a.a.), sharing 51 
an overall sequence identity of 87%, the murine ortholog is shorter in virtue of an additional 52 
N-terminal SRCR domain (3) (Figure 1 A, Supplementary Fig. 1).  53 
Produced predominantly by neurons of the central and peripheral nervous systems, NT is 54 
stocked in synaptic vesicles and released in an activity-dependant manner (4; 5). Upon 55 
secretion, NT cleaves the large proteoglycan Agrin, its only known substrate, generating two 56 
C-terminal fragments. This event is likely responsible for the roles played by NT in 57 
neuromuscular junction maintenance/turnover and in neuronal plasticity (4-7). Such is the 58 
importance of this cleavage event that de-regulation and/or inactivation result, respectively, 59 
in Sarcopoenia (muscle wasting disease of the elderly) (7) and non-syndromic mental 60 
retardation (4). 61 
While the significance of the catalytic domain has been touched upon, the role and relevance 62 
of the accessory domains remain unclear. Nonetheless it would be reasonable to attribute 63 
them with a role in protein-protein interaction and/or substrate recognition. Indeed, literature 64 
reports two potential NT interactors, in addition to the substrate Agrin, identified through 65 
yeast two-hybrid screening experiments: the product of seizure related gene 6 (Sez-6) (8) and 66 
the Integral Membrane Protein 2A (Itm2a) (8). These have been seen to influence, 67 
respectively, neuronal development and function (9; 10), and the differentiation of different 68 
tissue/cell types (11-13), among which skeletal muscle (14). NT’s interaction with Sez-6 has 69 
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been tied to one of the accessory domains: the Kr domain (8). Conversely, the domain(s) 70 
responsible for interacting with Itm2a has yet to be identified. 71 
The scavenger receptor cysteine-rich (SRCR) domain is a small (90-110 residues) 72 
distinguishing element of a broad superfamily of proteins whose members span different 73 
functional roles (15-17). It displays a highly conserved structure with five anti-parallel beta 74 
strands cradling an alpha helix and a distinct disulfide bridge architecture (18; 20-23). A 75 
feature which has been used to identify two types of SRCR domains, A and B, bearing 76 
respectively 6 and 8 cysteines. While the number of cysteines differs, the relative pairing is 77 
surprisingly consistent and tends to form as follows: C1-C4, C2-C7, C3-C8 and C5-C6. The 78 
first pair distinguishes types A and B as it is present exclusively in the latter (16). Members 79 
of the SRCR superfamily can share little functional similarity playing roles in immune 80 
response (18), cell differentiation (24), apoptosis (25) and tumor suppression alike. While it 81 
has been difficult to assign a univocal function to SRCR domains, a commonality can be 82 
drawn across several SRCR superfamily members, broadly attributing the SRCR domain with 83 
a role in protein-protein/protein-substrate interaction (26). It is therefore likely NT SRCR 84 
domains may mediate interactions with the surrounding environment. They could be 85 
responsible for the reported glycosaminoglycan and heparin binding capabilities (27), 86 
contribute to its specificity, mediate its localized lingering at the synapse (19), contribute to 87 
its specificity, mediate its localized lingering at the synapse (20) and/or be involved in 88 
binding to, as of yet, unidentified partners. Of NT’s accessory domains only the structure of 89 
the Kr domain has been successfully determined and assigned a possible role (21; 8). The 90 
lack of structural information pertaining to the remaining domains limits our functional 91 
understanding of NT. As such new structural data on the SP or SRCR domains might provide 92 
key insights on the mechanisms underlying NT’s biological role. 93 
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Here we report the recombinant production, purification, crystallization and crystal structure 94 
determination of the third SRCR domain of murine NT (mmNT-SRCR3), and analysis of its 95 
molecular architecture based on comparisons with homologous SRCR domains. Our 96 
structural data constitute a solid additional step towards the understanding of NT’s molecular 97 
interactions and biological functions. 98 
 99 
Results  100 
Purification of mmNT-SRCR3 101 
Owing to the high cysteine content of extracellular SRCR domains, we produced the mmNT-102 
SRCR3 in soluble form using a E. coli strain particularly adapted to facilitate disulfide bond 103 
formation. Purification of mmNT-SRCR3 was performed using a two-step immobilized Ni-104 
affinity chromatography (Ni-IMAC) followed by size-exclusion chromatography (SEC) 105 
(Supplementary Fig. 2). The purified material was used for crystallization experiments and 106 
protein characterization studies in solution.  107 
 108 
Crystal structure of mmNT-SRCR3 109 
A single mmNT-SRCR3 crystal allowed complete X-ray data collection and structure 110 
determination (Figure 1 B); data processing and structure refinement statistics are reported in 111 
table 1. This process highlighted the presence of two mmNT-SRCR3 monomers in the 112 
asymmetric unit assembling into what appeared to be a crystallographic dimer (Figure 1 C). 113 
Each monomer presents a very compact fold with a central alpha helix (α1) nested in five 114 
beta strands (β1-β5) forming a twisted anti-parallel cradle (Figure 1 B). The B-factor 115 
distribution across the structure highlights the high stability of the central core and 116 
progressive flexibility of the peripheral loops interconnecting the secondary structure 117 
elements (Figure 1 C). Of particular interest is the Val466–Asn474 segment, whose flexibility 118 
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is such that the electron density map of that region is very poor despite the 1.7-Å resolution 119 
(Supplementary Fig. 3). 120 
Each mmNT-SRCR3 model spans 107 residues and lacks the final C-terminal “KKASS” 121 
sequence, owing to the high mobility of this five-residue tail. Superposition of the two 122 
monomers found in the asymmetric unit and analysis of the root mean square deviation 123 
(r.m.s.d) shows that the only visible significant difference is located in the aforementioned 124 
Val466–Asn474 loop, further supporting its flexible nature (Figure 1 D). Calculations of 125 
surface electrostatic potentials using CCP4mg (22) displayed a disc-like shape with mixed 126 
charge distribution along its sides and two opposite faces, one almost fully hydrophobic and 127 
the other displaying a patch of negative charges (Figure 1 E). 128 
 129 
SEC-SAXS analysis 130 
In order to assess the oligomeric state of the purified protein sample in solution, and thus 131 
ascertain the nature of the mmNT-SRCR3 dimer observed in the crystal packing (Figure 1 C), 132 
we performed a SEC-small angle x-ray scattering (SEC-SAXS) experiment. The initial 133 
chromatogram displayed a well-defined peak with good scattering intensities and a very 134 
homogeneous mass distribution (Figure 2 A). mmNT-SRCR3 presents as a monodisperse 135 
species with an MW of 12 kDa calculated from averaged peak intensities (Table 2). This is in 136 
line with the 12.5 kDa calculated for a monomer of this construct and incompatible with 137 
higher order oligomeric species. CRYSOL (23) was used to compare the averaged scattering 138 
curve of the SEC-SAXS peak to a theoretically calculated scattering curve for our 139 
crystallographic structure. The single mmNT-SRCR3 monomer displayed a very good fit (2 140 
= 1.4) with the in-solution data (Figure 2 B), ruling the dimer as induced by the 141 




Comparison with other SRCR domains 144 
To better understand the functional role of NT’s SRCR domains, we used the DALI  server 145 
(24) to compare this structure with other entries in the Protein Data Bank (PDB). This search 146 
returned several high scoring matches which were manually filtered to remove redundancies 147 
resulting in a list of only 8 hits (Table 3). While limited in sequence identity, structural 148 
superpositions with mmNT-SRCR3 (Figure 3 A) evidenced a high degree of structural 149 
conservation, strongest within the central core and with greater variability in the peripheral 150 
loops. Comparison with an expanded pool of homologs using ConSurf (25) highlighted a 151 
similar trend for sequence conservation. When mapped to the structure of mmNT-SRCR3, it 152 
was possible to see how the areas of greater sequence identity, for the most part, 153 
corresponded to highly conserved secondary structure elements forming the domain core 154 
(Figure 3 B). Conversely the more flexible external loops displayed a significantly greater 155 
compositional variability. Of particular note is the β4 strand that, while being one of five core 156 
β strands displays little to no amino acid conservation (Figure 3 C). 157 
DALI matches with > 30% identity evidenced several perfectly conserved residues which 158 
were mirrored in ConSurf alignments. Among these is a six-cysteine network (residues 411, 159 
424, 455, 465, 475, and 485) responsible for the archetypical SRCR domain disulfide bridges 160 
(Figure 3 B). This canonical pairing is expressed relative to type B SRCR domains and while 161 
type A domains lack the C1-C4 pair, the relative numbering of the other pairs remains 162 
conventionally and structurally unaltered. Therefore, in mmNT-SRCR3 we found that 163 
Cys411-Cys475 corresponds to the C2-C7 pair, while Cys424-Cys485 and Cys455-Cys465 164 
correspond to the C3-C8 and C5-C6 pairs, respectively. Residues Gly391, Gly397, Glu400, 165 
Ala420, Val422, Leu427, Gly457, Glu459 and Val483 are also fully conserved (Figure 3 C). 166 
Of these, Ala420, Val422 and Leu427 can be mapped to the central helix while Gly397, 167 
Glu400 and Val483 can be found on strands β2 and β5, respectively (Figure 3 B). 168 
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Conversely, the remaining Gly391, Gly457 and Glu459 locate on the more flexible, and 169 
generally less conserved, external loops (Figure 3 B). 170 
Comparison of mmNT-SRCR3 with other mmNT SRCR domains evidenced a certain extent 171 
of conservation (44-58% sequence identity) comparable to that of the highest DALI matches 172 
(Supplementary Fig. 1 B). Extending this analysis to include human NT evidenced how its 173 
SRCR domains 2-4 correspond, respectively, to mmNT SRCR domains 1-3, while the first 174 
human SRCR domain is not conserved across the two homologs (Supplementary Fig. 1B). 175 
 176 
Evidence for Ca2+ binding 177 
Given the significant contributions of Ca2+ to NT activity (5), and the reported Ca2+-based 178 
modulation of SRCR-mediated interactions (18; 26), we investigated whether mmNT-SRCR3 179 
might contribute in similar fashion. Therefore, an Isothermal Titration Calorimetry (ITC) 180 
experiment was conducted in presence of CaCl2. This evidenced a Ca
2+ binding to mmNT-181 
SRCR3 (Figure 4 A), with Kd = 10.1 mM, ΔH = -7.7 Kcal/mol, ΔS = -16.8 cal/mol/deg. 182 
A comparison of mmNT-SRCR3 with the structure of the monomeric MARCO SRCR 183 
domain (18) highlighted a cluster of highly conserved residues coordinating a bivalent metal-184 
ion in MARCO (Figure 4 B). These correspond to amino acids Asp412-Asp413, His473, 185 
Asn474 and Glu479, that significantly contribute mmNT-SRCR3’s negatively charged patch. 186 
Interestingly the same residues were seen to be perfectly conserved in the DMBT1 SRCR-1 187 
domain, known as well to display Ca2+ binding (27) (Figure 4 C). 188 
 189 
Discussion 190 
The scavenger receptor cysteine-rich domain groups numerous proteins with different 191 
functions in a large superfamily (15). However, the understanding of the specific function of 192 
SRCR domains is, to date, limited to a general consensus of protein-protein/protein-ligand 193 
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interaction. The solution of the structure of the third SRCR domain of murine Neurotrypsin 194 
(mmNT-SRCR3) and its analysis highlighted several interesting features that might provide a 195 
functional insight both in regards to NT and SRCR domains in general. Most striking of all 196 
was the degree of similarity with the available homologous structures despite a generally 197 
poor sequence conservation (Table 3).  198 
At the core of mmNT-SRCR3 is an extremely stable secondary structure element 199 
organization which seems to be perfectly conserved across available structures. Such 200 
variability could be traced to the more flexible external loops, most notably the Val466-201 
Asn474 loop. This region not only displayed the highest mobility across homologs but also 202 
within the mmNT-SRCR3 monomers observed in the crystallographic dimer. Mapping of 203 
sequence conservation to the structure of mmNT-SRCR3 showed that the least conserved 204 
residues were located on this and other peripheral flexible loops, while the core secondary 205 
structure elements bore the majority of highly conserved amino acids. Of particular note are: 206 
a six-cysteine network responsible for the typical disulfide bond architecture of SRCR 207 
domains, and several perfectly conserved residues (Gly397, Glu400, Ala420, Val422, 208 
Leu427, and Val483) mapped to the highly stable core. These, owing to their localization and 209 
conservation, are likely to provide essential contributions to the fold of SRCR domains. 210 
Conversely, three additional highly conserved residues (Gly391, Gly457 and Glu459), 211 
mapped to the more flexible loop regions, and the 4 secondary structure element, which 212 
displays structural but not compositional conservation, might contribute to SRCR domain 213 
function. 214 
Among the more conserved regions two stretches, spanning Gly397–Val401 and Trp407–215 
Asp412 respectively, should be mentioned owing to their documented evolutionary 216 
conservation (28). The first likely contributes functionally, as similar consensus sequences 217 
were seen to mediate protein-target interaction in other SRCR-SF members including 218 
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MARCO (29), DMBT1 (35), CD163 (30), as well as structurally, given its mapping to the 219 
highly conserved 1 secondary structure element. Conversely, the second has yet to be 220 
assigned with a functional role but it is thought that the conservation of this stretch is 221 
structurally related.  222 
Owing to structural conservation it is possible to suppose a protein-target role for mmNT-223 
SRCR3. Additional observations drawn from that structure and other SRCR-SF members 224 
might hint at its more specific function in relation to NT. Notably, analysis of surface charge 225 
distribution of mmNT-SRCR3 evidenced a negatively charged patch corresponding to a 226 
cluster of residues (Asp412, Asp413, His473, Asn474 and Glu479), conserved in the metal-227 
ion binding MARCO SRCR domain (18), that might be involved in Ca2+ ion binding known 228 
to be important for NT enzymatic activity (31). A plausible hypothesis, given that ITC 229 
experiments showed Ca2+ binding for mmNT-SRCR3 and that other SRCR-SF members 230 
(MARCO, DMBT1 and CD163) also display a Ca2+ dependant modulation mapped to their 231 
SRCR domains (32; 30; 18). Further analogies can be speculated regarding the nature of 232 
possible binding partners. As several SRCR-SF members are known to bind to bacteria (32; 233 
27), lipopolysaccarides (LPS) directly (29; 33) or glycoproteins (34) via their SRCR domains. 234 
Thus it is possible that NT SRCR domains might mediate similar interactions between NT 235 
and its heavily glycosylated substrate Agrin (19). 236 
Finally, cross-comparison of human and murine NT evidenced how the first SRCR domain in 237 
the human NT sequence represents the principal source of divergence between the two 238 
homologs. Surprisingly, also the residues putatively coordinating Ca2+ in mmNT-SRCR3 are 239 
well conserved across all NT SRCR domains, except for human NT-SRCR1 (Supplementary 240 
Fig. 4). An observation which hints at a possible lack of Ca2+ binding for that SRCR domain 241 
and that, in conjunction with its absence in murine NT, opens to speculation regarding the 242 
function and relevance of the human NT SRCR1. 243 
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In conclusion, it seems plausible that the broad protein-target interaction attributed to SRCR 244 
domains might be mediated by the highly conserved nature of their core structure. While the 245 
more structurally and compositionally variable regions could be responsible for more 246 
nuanced and specific functional aspects such as ligand recognition. Finally in regards to NT, 247 
our characterization of mmNT-SRCR3 allowed us to identify a Ca2+ binding site and infer, by 248 




Materials and methods  251 
Molecular cloning, recombinant expression and purification 252 
The cDNA encoding for the third SRCR domain of murine Neurotrypsin (UniProt id O08762, 253 
residues 383-494) was obtained from Source Bioscience (I.M.A.G.E. clone ID 3665834), 254 
amplified with a Phusion DNA polymerase (Thermo Fisher Scientific) using oligos 255 
AAAGATCTGGTTTTCCCATCAGACTAGTGGATG (forward) and 256 
AAGCGGCCGCACTTGATGCTTTCTTCTCTAAATAG (reverse), and inserted into the 257 
pCIOX recombinant expression vector (Addgene), yielding the final construct bearing an N-258 
terminal 8-His-SUMO tag. This plasmid was transformed into chemically competent 259 
Escherichia coli SHuffle T7 cells (New England Biolabs), which were used for protein 260 
production. 261 
A small culture of transformed cells was grown over night shaking at 30 °C in LB + 262 
kanamycin (50 g/ml) and used to inoculate, in a 1:100 ratio, a larger volume (1 - 6 L) of 263 
autoinducing ZYP-5052 media (35) for large-scale production. Inoculated media was 264 
incubated shaking at 30 °C for 5 h, after which the temperature was lowered to 20 °C to 265 
induce recombinant protein expression, and further incubated for 20 h. 266 
Cells were harvested by centrifugation (5000 x g, 15 min, 4 °C) with a swinging bucket 267 
centrifuge (Beckman Coulter). The supernatant was discarded and the cells were resuspended 268 
in buffer A (25 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid 269 
(HEPES)/NaOH, 0.5 M NaCl, pH 8) in a 1:5 (w/v) wet cell pellet-to-buffer ratio. This 270 
suspension was placed on ice for 30 minutes and then sonicated (80% amplitude, 8 cycles 271 
with 40 s on/20 s off pulses) to lyse the cells. Cell debris was removed by centrifugation 272 
(10’000 x g, 50 min, 4 °C) and the supernatant was filtered with a 0.45 m syringe filter 273 
(Sartorius). The clarified lysate was loaded on a 5 mL HisTrap (GE Healthcare) column, pre-274 
conditioned with buffer A, at a rate of 1 mL/min. Unbound material was washed from the 275 
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column with buffer A and non-specifically bound contaminants were removed with buffer A 276 
supplemented with 25 mM imidazole. mmNT-SRCR3 was eluted by further increasing the 277 
imidazole concentration to 250 mM. The eluted fractions were pooled, supplemented with 278 
SUMO protease (1.2 mg/mL stock, 1:300 v/v) and dialyzed overnight at 4 °C against buffer 279 
A. Following dialysis the sample was subject to centrifugation (5000 x g, 4 °C, 15 min) and 280 
the supernatant was loaded onto a 1 mL HisTrap column (GE Healthcare). Successful 281 
removal of the His-SUMO tag was evaluated through sample recovery in the flow through 282 
fractions, which were further purified by gel filtration on a Superdex 75 10/300 GL column 283 
(GE Healthcare) equilibrated with 25 mM HEPES/NaOH, 100 mM NaCl, pH 8. At each step 284 
of protein purification, samples were collected and analysed using SDS-PAGE. The final 285 
yield was ≈ 2 mg of pure protein per gram of bacterial cells. 286 
 287 
Crystallization, X-ray Data collection and processing  288 
For crystallization screening the protein was concentrated to 20 mg/mL with a 5 kDa MWCO 289 
Vivaspin12 concentrator (Sartorius). Crystallization was performed using the sitting-drop 290 
vapor diffusion method at both 4 and 20 °C. Drops were set up in a volumetric 1:1 protein-to-291 
precipitant solution ratio using an Oryx8 crystallization robot (Douglas Instruments) with 292 
MRC 96-well PS plates (SwissSci). Initial screening performed with commercial screens 293 
yielded thin microcrystals, not suitable for diffraction testing, in numerous conditions. 294 
Optimization of initial crystallisation hits was performed by hand using the sitting drop 295 
method. The best crystals were obtained at 4 °C, over the span of a month, by mixing 296 
mmNT-SRCR3 concentrated at 19 mg/mL with a solution composed of 16% PEG3350, 0.1 297 
M Tri-Sodium citrate, pH 7.5. Prior to flash-cooling in liquid nitrogen, crystals were 298 
harvested with nylon cryoloops (Hampton Research) and briefly soaked into a cryo-299 
protectant solution (19% PEG3350, 0.1 M Tri-Sodium citrate, 20% Glycerol). X-ray 300 
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diffraction data were collected at 100 K at the ID30A-3 beamline of the ESRF synchrotron. 301 
Data were indexed and integrated using XDS (36) and scaled using Aimless (37). Data 302 
collection statistics are summarized in Table 1. 303 
 304 
Structure determination and refinement  305 
The structure of mmNT-SRCR3 was solved at 1.7 Å by molecular replacement using the 306 
structure of the Mac-2 binding protein (M2BP) SRCR domain (pdb: 1BY2) (38) as search 307 
model. This model (50% sequence identity to mmNT-SRCR3) was selected based on 308 
conservation of sequence identity as evaluated using NCBI BLAST (39). Prior to molecular 309 
replacement, the sequences of mmNT-SRCR3 and M2BP SRCR were aligned using EBI 310 
MUSCLE (40) and non-conserved residues were adjusted using CHAINSAW (41). The 311 
resulting model was used  in molecular replacement with PHASER (42). Two copies of the 312 
search model were found constituting the asymmetric unit, with a Vm of 3.11 Å
3 and 60% 313 
solvent content. The structure was refined with successive steps of manual building in COOT 314 
(43) and automated refinement with REFMAC5 (44). Model validation was performed with 315 
MolProbity (45). Refinement statistics for the final model are reported in Table 1 as 316 
deposited to the PDB under accession code 6H8M. Electrostatic surface calculations and 317 
representations were generated with CCP4mg (22). Other structural images were generated 318 
with UCSF Chimera (46) .  319 
 320 
SEC-SAXS analysis 321 
Size exclusion chromatography coupled to small-angle X-ray scattering (SEC-SAXS) 322 
analysis was performed at the BM29 beamline of the ESRF synchrotron in Grenoble (France) 323 
using a protocol adapted from (47). The protein was concentrated to 15 mg/mL and a 15 L 324 
sample was run on a Superdex 75 Increase 3.2/300 column (GE Healthcare) equilibrated in 325 
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25 mM HEPES/NaOH, 0.1 M NaCl, pH 8 and mounted on a Nexera High Pressure 326 
Liquid/Chromatography (HPLC; Shimadzu) system. SAXS data were collected from the 327 
sample capillary mounted on line with the HPLC system, using a Pilatus 1 M detector 328 
(Dectris) positioned at distance of 2.87 m allowing a global q range of 0.03–4.5 nm with 12.5 329 
keV energy. Analysis of scattering intensities was performed using CHROMIXS (48) and the 330 
ATSAS suite (49). Comparison of in-solution scattering to crystallographic data was carried 331 
out with CRYSOL (23). Details of SEC-SAXS data collection and analysis are summarized 332 
in Table 2 as deposited in SASBDB under accession code SASDES5. 333 
 334 
Isothermal Titration Calorimetry 335 
Titrations were carried out at 25°C in 100 mM NaCl 25 mM HEPES/NaOH pH8 using the 336 
high feedback mode of a MicroCal ITC200 instrument (Malvern Instruments, Worcestershire, 337 
UK). The concentration of mmNT-SRCR3 in the cell was 1.2 mM, whereas the CaCl2 338 
solution in the syringe was at 120 mM. The first injection was kept to the minimum volume 339 
of 0.1 uL to allow complete equilibration of the cell. The following 19 titrations of CaCl2 340 
were performed using a 2 uL injection volume with a 120 sec. time interval while 341 
maintaining stirring at 750 rpm. The heat of dilution of 120 mM CaCl2 was determined by 342 
performing a second titration in which the cell was filled only with buffer while all other 343 
experimental parameters remained unaltered. The net contribution of binding of CaCl2 to 344 
mmNT-SRCR3 was calculated by subtracting the heat of dilution of CaCl2. Data were 345 
analyzed using the “One Set of Sites” curve fitting model (MicroCal ITC200 Origin). 346 
 347 
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Table 1. X-ray data collection and refinement statistics  370 
Data Collection  
Diffraction source  ESRF ID30A-3 
Wavelength (Å) 0.983 
Space group P 212121 
Cell parameters a, b, c (Å)  a = 57.8 Å, b = 62.9 Å, c = 84.5 Å,  =  =  = 90° 
Resolution range (Å)1,2 42.54 - 1.70 (1.73 - 1.70) 
Unique reflections 34576 (1785) 
Completeness (%) 100.0 (100.0) 
Multiplicity 6.9 (6.9) 
Mean (I/σ(I)) 15.5 (0.5) 
CC(1/2) 0.999 (0.434) 
Rsym 
3 0.049 (3.37) 
  
Refinement  
Rwork / Rfree 0.19 / 0.21 
No. of non-H atoms 1747 
   Protein 1662 
   Ligands 0 
   Waters 85 
r.m.s. deviations    
   Bonds (Å) 0.016 
   Angles (°) 1.699 
Average B factors (Å2)    
   Protein 65.3 
   Water 54.0 
Ramachandran favoured (%) 97.6 
Ramachandran allowed (%) 2.4 
 371 
1 Values for the outer shell are given in parentheses.  372 
2 Resolution limits were determined by applying a cut-off based on the mean intensity correlation coefficient of 373 
half-datasets (CC1/2) approximately of 0.5 (50). 374 
3 Rsym = Σ | I – <I> | / Σ I, where I is the observed intensity for a reflection and <I> is the average intensity 375 




Table 2. Summary of SEC-SAXS data collection and analysis 378 
Data Collection  
Light source and beamline ESRF BM29 
Beam energy (keV) 12.5 
Sample-detector distance (m) 2.867 
Exposure time (s) 1 
Sample cell thickness (mm) 1 
Temperature (°) 20 
Final q range (nm-1) 0.01 - 4 
  
Data Analysis  
Points used for Guinier analysis 27-173 
Guinier qRg limits 0.24 
Guinier Rg (nm) 1.54 ± 0.03 
I(0) (nm-1) 13.48 ± 0.02 
Dmax (nm) 5.8 





Table 3 List of homologous SRCR structures identified by DALI. 381 
Protein PDB Z-Score r.m.s.d. % id. 
Lysyl oxidase homolog 2 5ZE3 18.2 2.1 49 
CD6 5A2E 18.0 1.5 49 
Mac-2 binding protein (M2BP) 1BY2 18.0 1.8 50 
Scavenger receptor cysteine-rich type 1 protein m 5JFB 16.6 1.8 38 
Macrophage receptor (MARCO) 2OYA 13.7 1.7 52 
Human complement factor I 2XRC 11.2 2.2 31 
T-cell surface glycoprotein CD5 2JA4 7.5 2.4 27 




Figure Legends: 383 
Figure 1 - Three-dimensional structure of the third SRCR domain of murine NT. (A) domain 384 
organization of mouse and human NT, highlighting the localization of mmNT-SRCR3 within 385 
the multidomain enzyme architecture. Colouring of the domains highlights sequence 386 
conservation between homologous enzymes, as described in Supplementary Fig. 1. (B) 387 
Cartoon representation of mmNT-SRCR3 displaying its main secondary structure elements, 388 
-helix (1) in blue and -strands (1 – 5) in cyan. (C) Cartoon “putty” representation of 389 
the two mmNT-SRCR3 monomers found in the crystallographic asymmetric unit, coloured 390 
blue-red by B-factors (34.2 – 162.5 Å2). (D) Superposition of the two mmNT-SRCR3 391 
molecules found in the asymmetric unit. chain A is shown in red, chain B is shown in cyan. 392 
(E) Surface representation with colouring by electrostatic potential (-2.0 – +2.0 V), negative 393 
charges in red, positive charges in blue and neutral areas in white. Monomer is presented 394 
orientations highlighting main features: uncharged bottom, mixed charges on sides and 395 
negatively charged patch on top. 396 
 397 
Figure 2 – mmNT-SRCR3 SEC-SAXS analysis. (A) SEC-SAXS chromatogram showing 398 
mmNT-SRCR3 scattering intensities and profile of mass distribution across the peak. (B) 399 
Averaged experimental peak scattering curve, after buffer subtraction, plotted superimposed 400 
to a theoretical, CRYSOL-derived, scattering curve for an mmNT-SRCR3 monomer (2 = 401 
1.4). 402 
 403 
Figure 3 - Structural comparison of mmNT-SRCR3 with other SRCR domains. (A) 404 
Superposition with non-redundant DALI matches (Table 3) coloured red-yellow by r.m.s.d. 405 
(0.39 – 6.32 Å). (B) Cartoon representation of mmNT-SRCR3 in two orientations, coloured 406 
cyan-brown (0 – 100%) by residue conservation after ConSurf analysis. The left panel maps 407 
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highly conserved residues from SRCR structure sequence alignments, while the right panel 408 
maps the principal secondary structure elements and the archetypical SRCR disulfide bridge 409 
organization. The C1-C4 pair is absent in SRCR type A domains, residues Cys411-Cys475 410 
correspond to the C2-C7 pair, Cys424-Cys485 to the C3-C8 pair and Cys455-Cys465 to the 411 
C5-C6 pair. (C) Sequence alignment of SRCR structures identified by DALI analysis of 412 
mmNT-SRCR3. Identical residues boxed in red, residues with 70% conservation boxed in 413 
yellow. mmNT-SRCR3 secondary structure elements displayed above alignment and 414 
consensus sequence with 70% conservation under alignment. Image created using ESPRIPT3 415 
(51). 416 
 417 
Figure 4 – Evidence for mmNT-SRCR3 Ca2+ binding. (A) Isothermal calorimetric titration of 418 
CaCl2 (120 mM) with purified mmNT-SRCR3. Heat variation generated by each injection of 419 
titrant at each time interval (top panel) and the integration of each peak and the amount of 420 
heat produced (lower panel). (B) Structural inference of mmNT-SRCR3 binding of metal 421 
ions. Top panel, residues contributing to the formation of the negatively charged patch on 422 
mmNT-SRCR3 likely bind metal ions. Bottom panel, superopsition of mmNT-SRCR3 (blue) 423 
with monomeric MARCO (cyan, PDB: 2OY3) coordinating Mg2+ (green sphere) via those 424 
same amino acids. Side chains of residues Asp412, Asp413 and Glu479 display almost 425 
identical conformations, while Asn474 and His473 show higher flexibility. (C) Sequence 426 
alignment of mmNT-SRCR3 against MARCO and DMBT1 SRCR domains known to bind 427 
Ca2+. Blue arrows and boxes indicate residues evidenced in (B) which are perfectly conserved 428 
across all three proteins. Perfectly conserved residues boxed in red, residues with 70% 429 
conservation are boxed in yellow. Evaluation of sequence conservation is shown under 430 
alignment; symbols indicate: ! = Ile or Val, $ = Leu or Met, % = Phe or Tyr, # = Asn, Asp, 431 
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